Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis

3 Sept 2020

Abstract excerpt

Altered metabolism of glucose, lipid and glutamine is a prominent hallmark of cancer cells. Currently, cell heterogeneity is believed to be the main cause of poor prognosis of glioblastoma (GBM) and is closely related to relapse caused by therapy resistance. However, the comprehensive model of genes related to glucose-, lipid- and glutamine-metabolism associated with the prognosis of GBM remains unclear, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33042807
DOI: 10.3389/fonc.2020.01631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic AnalysisPMID 33042807Read ↗

Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastomaSemantic proximity Read ↗

Exploration of prognosis and immune infiltration characteristics in Glioblastoma Multiforme based on Lipid Metabolism related GenesSemantic proximity Read ↗

A Novel Glucose Metabolism‐Related Gene Signature for Overall Survival Prediction in Patients with GlioblastomaSemantic proximity Read ↗

Advancing glioblastoma treatment by targeting metabolismSemantic proximity Read ↗

Integrative multi-omics Analysis Proposes a Metabolic Classification of Gliomas: Distinct Metabolic States, Immune Infiltration, and PrognosisSemantic proximity Read ↗

The prognosis model of glioblastoma was constructed based on lactic acid metabolism-related genesSemantic proximity Read ↗

Prognostic prediction model for glioblastoma: a metabolic gene signature and independent external validationSemantic proximity Read ↗

A Novel Glycolysis-Related Gene Signature that can Predict the Prognosis of Glioblastoma PatientsSemantic proximity Read ↗

Amino acid metabolism‐related gene expression‐based risk signature can better predict overall survival for gliomaSemantic proximity Read ↗

High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower SurvivalSemantic proximity Read ↗

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based ApproachSemantic proximity Read ↗

A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.